中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月5日星期六
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药
  护理研究 本期目录 | 过刊浏览 | 高级检索 |
基于Caprini 风险评估的信息化平台在髋关节骨折患者中的应用效果及对术后深静脉血栓的影响
宋 婷 王 慧 周玉妹▲
南昌大学第二附属医院骨科,江西南昌 330000
Application effect of information platform based on Caprini risk assessment in patients with hip fracture and its influence on postoperative deep vein thrombosis
SONG Ting WANG Hui ZHOU Yumei▲#br#
Department of Orthopaedics,the Second Affiliated Hospital of Nanchang University,Jiangxi Province,Nanchang 330000,China
全文: PDF (624 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要  目的 探讨基于Caprini 风险评估的信息化平台在髋关节骨折患者中的应用效果及其对术后深静脉血栓的影响。方法 选择2020 年1 月至2023 年1 月南昌大学第二附属医院收治的120 例髋关节骨折患者作为研究对象,使用随机数字表法将其分为两组,对照组患者(60 例)采取常规护理措施,观察组患者(60 例)进行Caprini 风险评估分级后基于信息化平台与自身情况进行对应的护理措施,收集两组患者干预前1 d 至干预后4 周的相关数据,比较两组患者Harris 髋关节功能评分(HHS)、Barthel 指数(BI)、白细胞计数(WBC)、降钙素原(PCT)、C-反应蛋白(CRP)、血小板(PLT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、D-二聚体(D-D)、患者满意度评分、深静脉血栓发生率及深静脉血栓发生患者血栓最大宽度。结果 干预后,观察组患者满意度、术后恢复指标(HHS、BI)高于对照组,差异有统计学意义(P<0.05);观察组炎症指标(WBC、PCT、CRP)、深静脉血栓发生率、深静脉血栓发生患者血栓最大宽度低于对照组,差异有统计学意义(P<0.05);干预后,观察组患者PLT、APTT、D-D高于对照组,TT 低于对照组,差异有统计学意义(P<0.05)。结论 基于Caprini 风险评估下的信息化平台构建的护理措施对髋关节骨折术后患者的术后恢复及深静脉血栓的预防均具较好效果。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 Caprini 风险评估髋关节骨折术深静脉血栓预防    
Abstract
Objective To explore the application effect of information platform based on Caprini risk assessment in patients with hip fracture and its influence on postoperative deep vein thrombosis.Methods A total of 120 patients with hip fracture admitted to the Second Affiliated Hospital of Nanchang University from January 2020 to January 2023 were selected as the study objects and they were divided into two groups using random number table method.Patients in the control group (60 cases)were given routine nursing measures,while patients in the observation group (60 cases)were given nursing measures based on the information platform and their own conditions after Caprini risk assessment classification.Relevant data of patients in both groups were collected from 1 day before intervention to 4 weeks after intervention.The Harris hip score(HHS),Barthel index (BI),white blood cell (WBC),procalcitonin (PCT),C-reactive protein (CRP),platelet (PLT),activated partial thromboplastin time(APTT),thrombin time(TT),D-dimer(D-D),patient satisfaction score,incidence of deep vein thrombosis and maximum width of thrombus in patients with deep vein thrombosis were compared between the two groups.Results After intervention,the satisfaction and postoperative recovery index (HHS,BI) of patients in observation group were higher than those in control group,the differences were statistically significant (P<0.05).The inflammation index (WBC,PCT,CRP),the incidence of deep vein thrombosis,and the maximum width of thrombus in patients with deep vein thrombosis in observation group were lower than those in control group,with statistical significances (P<0.05).After intervention,PLT,APTT,D-D in observation group were higher than those in control group,and TT was lower than those in control group,with statistical significances (P<0.05).Conclusion The nursing measures constructed by the information platform based on Caprini risk assessment have good effects on the postoperative recovery of patients with hip fracture and the prevention of deep vein thrombosis.
Key wordsCaprini risk assessment    Hip fracture    Deep vein thrombosis    Prophylaxis
    
基金资助:江西省中医药管理局科技计划项目(2022A194)。
引用本文:   
宋婷;王慧;周玉妹. 基于Caprini 风险评估的信息化平台在髋关节骨折患者中的应用效果及对术后深静脉血栓的影响[J]. 中国当代医药, 2024, 31(18): 167-170转175.
SONG Ting WANG Hui ZHOU Yumei▲. Application effect of information platform based on Caprini risk assessment in patients with hip fracture and its influence on postoperative deep vein thrombosis. 中国当代医药, 2024, 31(18): 167-170转175.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2024/V31/I18/167
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载